This line says it all...“We are maintaining our Buy rating but lowering our target to $2.10 (was $2.40) mainly owing to increasing our assumed dilution from additional financings,” McAuley said.
Talk about conflicting objectives ! Drag your feet and secure a much bigger peice of the pie, or just get'er done?
MM